However, an expanding oncology therapeutic landscape and advances in genomic tumour analysis may help direct the choice of potentially active treatments, such as those targeting vascular endothelial growth factor (VEGF) or immunotherapy. The gene discussed is VEGFA; the disease is neoplasm.